Swift Biosciences, LGC BioSearch Partner on Targeted Sequenc

Swift Biosciences has partnered with LGC Biosearch Technologies to incorporate Swift's targeted sequencing technology into LGC's kits and service offerings for the worldwide ag-bio market.
 
As part of the collaboration, LGC will be Swift's worldwide partner for amplicon-based targeted sequencing assays for genotyping ag-bio samples, including crop species and animals.
 
Based off Swift's Accel-Amplicon products, LGC's products and services will use Swift's primer design, algorithms, multiplex PCR chemistry, and next-generation sequencing library preparation reagents to achieve mid-density SNP genotyping by sequencing for high-sample-throughput applications.
 
"Swift developed a patented, multiplex PCR library preparation technology to enable sequencing thousands of targets per assay and primer design software that accommodates various plant and animal genomes," Drew McUsic, senior product manager at Ann Arbor, Michigan-based Swift, said in a statement. "Partnering with LGC allows Swift to focus the application of that technology into the ag-bio market."
 
Financial details of the collaboration were undisclosed.
 
"The ag-bio sequencing space is developing rapidly and it demands cost-effective, convenient assays capable of reliably delivering broad genetic trait profiles to inform decisions in breeding and agricultural product development," Joris Parmentier, LGC Biosearch's strategic marketing manager, said in a statement. "Swift's patented technology complements our NGS portfolio and allows us to provide a targeted genotyping by sequencing solution to our customers that is simple, fast, and cost-effective enough to enable the sample throughput required and accelerate their breeding programs."